PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 105 filers reported holding PASSAGE BIO INC in Q3 2021. The put-call ratio across all filers is 2.13 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $1,401,000 | -78.7% | 140,699 | -71.6% | 0.05% | -78.7% |
Q2 2021 | $6,566,000 | -24.8% | 495,931 | -0.7% | 0.24% | -24.1% |
Q1 2021 | $8,732,000 | +0.2% | 499,541 | +46.6% | 0.32% | +9.0% |
Q4 2020 | $8,712,000 | +94.5% | 340,698 | -0.3% | 0.29% | +57.1% |
Q3 2020 | $4,479,000 | -53.5% | 341,627 | -3.2% | 0.18% | -56.2% |
Q2 2020 | $9,640,000 | +72.6% | 352,743 | -0.5% | 0.42% | +30.0% |
Q1 2020 | $5,585,000 | – | 354,601 | – | 0.32% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 2,497,922 | $63,872,000 | 14.76% |
FRAZIER MANAGEMENT LLC | 5,009,219 | $128,086,000 | 9.86% |
HIGHLINE CAPITAL MANAGEMENT, L.P. | 602,248 | $15,399,000 | 7.53% |
Vivo Capital, LLC | 1,487,038 | $38,024,000 | 1.70% |
Boxer Capital, LLC | 1,928,315 | $49,307,000 | 1.58% |
Orbimed Advisors | 6,962,899 | $178,041,000 | 1.56% |
Logos Global Management LP | 344,438 | $8,807,000 | 0.76% |
EMERALD ADVISERS, LLC | 340,698 | $8,712,000 | 0.29% |
Ikarian Capital, LLC | 136,697 | $3,495,000 | 0.15% |
Weiss Multi-Strategy Advisers LLC | 300,554 | $7,685,000 | 0.15% |